• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Mol Sci . Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease

tetano

Editor, Senior Moderator
Int J Mol Sci


. 2020 Dec 15;21(24):E9523.
doi: 10.3390/ijms21249523.
Identification of Host Cellular Protein Substrates of SARS-COV-2 Main Protease


M?ri? Miczi[SUP] 1 2 [/SUP], M?ria Golda[SUP] 1 2 [/SUP], Bal?zs Kunkli[SUP] 1 2 [/SUP], Tibor Nagy[SUP] 3 [/SUP], J?zsef Tőzs?r[SUP] 1 [/SUP], J?nos Andr?s M?ty?n[SUP] 1 [/SUP]



Affiliations

Abstract

The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of coronavirus disease-19 (COVID-19) being associated with severe pneumonia. Like with other viruses, the interaction of SARS-CoV-2 with host cell proteins is necessary for successful replication, and cleavage of cellular targets by the viral protease also may contribute to the pathogenesis, but knowledge about the human proteins that are processed by the main protease (3CLpro) of SARS-CoV-2 is still limited. We tested the prediction potentials of two different in silico methods for the identification of SARS-CoV-2 3CLpro cleavage sites in human proteins. Short stretches of homologous host-pathogen protein sequences (SSHHPS) that are present in SARS-CoV-2 polyprotein and human proteins were identified using BLAST analysis, and the NetCorona 1.0 webserver was used to successfully predict cleavage sites, although this method was primarily developed for SARS-CoV. Human C-terminal-binding protein 1 (CTBP1) was found to be cleaved in vitro by SARS-CoV-2 3CLpro, the existence of the cleavage site was proved experimentally by using a His[SUB]6[/SUB]-MBP-mEYFP recombinant substrate containing the predicted target sequence. Our results highlight both potentials and limitations of the tested algorithms. The identification of candidate host substrates of 3CLpro may help better develop an understanding of the molecular mechanisms behind the replication and pathogenesis of SARS-CoV-2.

Keywords: 3CL protease; COVID-19; NetCorona; SARS; SARS-CoV-2; SSHHPS; cleavage site identification; cleavage site prediction; coronavirus; host protein cleavage; main protease.
 
Back
Top Bottom